Programme
EEROVAC TRAINING COURSE ON ROTAVIRUS
Monday 23 March
16.30 - 1830 EEROVAC TRAINING COURSE Federico Martinon-Torres
Timo Vesikari
Carlo Giaquinto
Hans-Iko Huppertz
4TH EEROVAC
Monday 23 March
19.00 Opening ceremony and opening Remarks Federico Martinón-Torres
19.15 Opening Lecture: The Continuing Rotavirus
Vaccine Story Timo Vesikari
20.00 Tapas and drinks
Tuesday 24 March
Session I European Progress from Decision Making to Introduction
Chair: Carlo Giaquinto and Hans-Iko Huppertz
9.00 Introduction: The RV vaccination map of Europe Carlo Giaquinto
9.10 ECDC analysis of the decision making process Pier Luigi Lopalco
9.40 UK experience in introduction of universal
RVimmunization Adam Finn
10.00 Germany - the road to STIKO recommendation Hans-Iko Huppertz
and afterwards
10.15 How France reversed its position Pierre Pothier
10.30–11.00 Coffee break / Poster viewing
Session II Current RV vaccines
Chair: Pierre van Damme and Federico Martinón-Torres
11.00 Update on RotaTeq SP-MSD (TBA)
11.30 Update on Rotarix GSK (TBA)
12.00 Vaccine long term effectiveness in the US Daniel Payne
12.20 Vaccine effectiveness in Europe Tessa Braeckman
12.40 ESPID/ESPGHAN Recommendations on
rotavirus vaccination Pierre van Damme
13.00–14.30 Lunch and Poster viewing
Session III Effect of Rotavirus Vaccination
Chair: Timo Vesikari and Osamu Nakagomi
14.30 RV Serotypes before and after RV Vaccinations
in Europe Miren Iturriza-Gómara
15.00 Effect of universal RV vaccination on VP7 and
VP4 subtypes Maria Hemming
15.20 Long-term shedding and formation of double
reassortants Timo Vesikari
15.40–16.00 Coffee break and Poster viewing
Session IV Adverse Effects
Chair: Roger Glass and Adam Finn
16.00 Intussusception experience from the US Umesh Parashar
16.20 Intussusception experience from Japan Toyoko Nakagomi
16.40 Intussusception experience from Europe Doris Oberle
17.00 Overall Discussion
Session V Best communications – Short oral presentations
Chair: Federico Martinón-Torres and Umesh Parashar
17.15-18.00
18.30 End of Day 1
21.30 Dinner
Wednesday 25 March
Session VI Rotavirus Vaccine Research
Chair: Osamu Nakagomi and Umesh Parashar
9.00 Indian live RV vaccines Roges Glass
9.20 Chinese lamb reassortant rotavirus vaccine Tai Guo
9.40 Non-live whole virus vaccine Baoming Jiang
10.00 Non-live VP8 vaccine Xi Jiang
10.20 Non-live VP6 vaccine Vesna Blazevic
10.40–11.00 Break and poster viewing
Session VII Rotavirus Research
Chair: Harry Greenberg and Miren Iturriza-Gómara
11.00 Protective mechanism of RV infection James Crowe
11.30 Interferon and rotavirus John Patton
12.00 Genetic determinants of RV pathogenicity Harry Greenberg
12.30 Closing Remarks Federico Martinón-Torres
Lunch and Departures
